Spencer Pharmaceutical Inc. (SPPH) Stock

No profile data available.

About Spencer Pharmaceutical Inc. (SPPH) stock

Spencer Pharmaceutical Inc. (SPPH) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Boston, United States.

In Q1 2004 (the quarter ended March 31, 2004) revenue was $670,214. Its market capitalization was $1.34 million as of October 8, 2026.

Figures from company filings and market data; latest fiscal year ended December 31, 2003; market data as of October 8, 2026.

Sector: Healthcare
Industry: Multi-Therapeutic Drug Manufacturing
Headquarters: Boston, United States
Exchange: OTC Markets OTCPK
Market cap: $1.34 million (October 8, 2026)

Frequently asked questions

What does Spencer Pharmaceutical do?

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases.

What is Spencer Pharmaceutical's market cap?

$1.34 million as of October 8, 2026.

What companies are similar to Spencer Pharmaceutical?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sunshine Biopharma, Inc. (SBFM), Amazonas Florestal, Ltd (AZFL), SK3 Group, Inc. (SKTO), Hemp, Inc (HEMP).

Similar companies

Sunshine Biopharma (SBFM)Amazonas Florestal (AZFL)SK3 (SKTO)Hemp (HEMP)Cann American (CNNA)Evofem Biosciences (EVFM)

Industry and sector

Pharmaceutical Preparation Manufacturing industry Manufacturing sector Healthcare sector data Stock screener Search all stocks

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.